Oestrogen receptor alpha (ERα) is a critical nuclear transcription factor that drives hormone‐dependent cancer progression—particularly in breast, ovarian, colorectal, prostate and endometrial cancers—by promoting tumour cell proliferation, survival and metastasis through genomic transcription and rapid kinase signalling pathways. This evidence concerns the gene ESR1 and neoplasm.